V CompBrief BY VELARION

Chief Medical Officer · GILEAD SCIENCES, INC. (GILD)

Dietmar Berger

FY2025 is the first fiscal year CompBrief holds for Dietmar Berger as a named executive officer of GILEAD SCIENCES; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$13,922,878

2nd of 5 named executive officers at Gilead Sciences by FY2025 total.

5 named officers on file for GILEAD SCIENCES, FY2025

See an example →

What this number hides

The filing gives the total. GILEAD SCIENCES’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how GILEAD SCIENCES’s whole pay program stands against its peers

  • GILEAD SCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GILD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 20, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-10.

Free

Get Dietmar Berger’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Dietmar Berger and every company like it: Velarion Intel, free for 3 days, no card →

Dietmar Berger compensation by year

GILEAD SCIENCES Summary Compensation Table · the one fiscal year held
In US dollars, as GILEAD SCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$969,231
Bonus$3,000,000
Stock awards$6,999,758
Option awards$1,000,043
Non-equity incentive$1,603,594
Pension and deferred compensation$0
All other$350,252
Total$13,922,878

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GILEAD SCIENCES, INC. DEF 14A filed March 20, 2026, accession 0001308179-26-000106, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GILEAD SCIENCES, INC. filed document, accession 0001308179-26-000106. Every figure is read from that document and cited to the page and table it appears in. Filed March 20, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU48,975$6,011,192—
RSU8,530$1,046,972—
PSU5,725$702,687—
Option37,710—$117.21

Per the Outstanding Equity Awards at Fiscal Year-End table in GILEAD SCIENCES, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

6 Form 4 lines since the FY2025 proxy (filed March 20, 2026)
current to 2026-11-10 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-09-10Tax withholding—263$144.8119,522
2026-09-10Exercise or conversion—533—19,785
2026-09-10Exercise or conversion derivative—533—46,395
2026-06-10Exercise or conversion—533—19,515
2026-06-10Tax withholding—263$121.4819,252
2026-06-10Exercise or conversion derivative—533—46,928

The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

GILEAD SCIENCES’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Daniel O'DayChairman and Chief Executive Officer$28,437,198
Dietmar Berger · this pageChief Medical Officer$13,922,878
Johanna MercierChief Commercial and Corporate Affairs Officer$9,300,643
Andrew DickinsonChief Financial Officer$8,765,616
Deborah TelmanFormer Executive Vice President, Corporate Affairs and General Counsel$5,004,669

Dietmar Berger's compensation dossier, GILEAD SCIENCES

You have read Dietmar Berger's totals and holdings. The dossier adds each equity grant GILEAD SCIENCES disclosed for Dietmar Berger and GILEAD SCIENCES's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full GILEAD SCIENCES compensation record

free company brief
GILEAD SCIENCES, INC. (GILD) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within GILEAD SCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GILEAD SCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order GILEAD SCIENCES's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GILEAD SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order GILD

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Dietmar Berger's compensation dossier